The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

INDIANAPOLIS, May 12, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today it plans to invest up to $550 million in its Diagnostics site in Indianapolis by 2030. The site will ...

Royston Roche has over a decade of experience in the capital markets. He started his career with Infosys BPM., where he worked for its clients BNY Mellon and Deutsche Bank. Later, he worked with ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United ...

COPENHAGEN, Denmark — The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight ...

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its tally of weight-loss candidates in clinical development to five.

Anita Hauser currently works at Bucher Industries AG, as Deputy Chairman from 2011, Bucher Hydraulics AG, as Deputy Chairman, Roche Holding AG, as Independent Non-Executive Director from 2017 ...

Hoffmann-La Roche Ltd., as Director, Zurich Chamber of Commerce, as Director from 2017, Swiss Innovation Park Foundation, as Director, TECHNOPARK Immobilien AG, as Trustee from 2012, American ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Roche says Trump's drug price order threatens its $50 billion US investment plans U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in ...